Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-04

FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)

View source ↗

Summary

The FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Inc, for their generic clopidogrel product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clopidogrel bisulfate (clopidogrel bisulfate)

Snippet

SUPPL AP for CLOPIDOGREL BISULFATE (CLOPIDOGREL BISULFATE)